Matthew Brams - 07 Jul 2025 Form 4 Insider Report for Cingulate Inc. (CING)

Role: EVP and Chief Medical Officer
Signature: /s/ Shane J. Schaffer, Attorney-in-Fact
Issuer symbol: CING
Transactions as of: 07 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Jul 2025, 18:00:06 UTC
Previous filing: 20 Feb 2025
Next filing: 10 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Brams Matthew	EVP and Chief Medical Officer	1901 W. 47TH PLACE, KANSAS CITY	/s/ Shane J. Schaffer, Attorney-in-Fact	08 Jul 2025	0001884361

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CING	Stock Option (right to Buy)	Award	$0	+52,500		$0.000000	52,500	07 Jul 2025	Common Stock	52,500	$4.42	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.